Worldwide: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Consolidated Appropriations Act Introduces Sweeping Reforms For Pharmacy Benefit Managers

PBMs contracted with group health plans will similarly need to remit to plans any rebates, fees, alternative discounts, and other remuneration received relating to utilization of drugs or drug spending.

United States Healthcare

CM

Crowell & Moring LLP

OIG Issues Medicare Advantage Industry Segment-Specific Compliance Program Guidance, Creating Implications For Downstream Entities

The U.S. Department of Health and Human Services' Office of Inspector General (OIG) has released updated Medicare Advantage Industry Segment-Specific Compliance Program...

United States Healthcare

DM

Duane Morris LLP

NSF Will Establish National Quantum And Nanotechnology Research Infrastructure; Letters Of Intent Are Due March 16, 2026

The U.S. National Science Foundation (NSF) announced on February 13, 2026, that it is investing up to $100 million to establish a nationwide network of open-access research facilities for quantum and nanoscale technologies...

United States Healthcare

BC

Bergeson & Campbell

The Wait Is Over: Information Blocking Enforcement Is Officially Here

The U.S. Department of Health and Human Services is moving from policy to enforcement under the 21st Century Cures Act...

United States Healthcare

HK

Holland & Knight

Cost Efficiency And Ethical Healthcare Will Increasingly Become Non-negotiable

United States Healthcare

AM

Alvarez & Marsal

Life Sciences Dealmaking Accelerates In 2026: Key Insights From EY's Firepower M&A Report

United States Healthcare

SR

McDermott Will & Schulte

Genetic Testing Enforcement Poised To Rise: What To Expect In The Coming Year

United States Healthcare

KM

Katten Muchin Rosenman LLP

Sweeping PBM Reforms Arrive: What The 2026 Federal Legislation Means For Pharmacies, Patients And Employers

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Express Scripts Settles PBM FTC Action And Must Make Fundamental Changes To PBM Model

United States Healthcare

GP

Goodwin Procter LLP

14th Annual Healthcare Fraud & Abuse Review

United States Healthcare

BB

Bass, Berry & Sims

Samsung And Regeneron Settle Aflibercept BPCIA Case

United States Healthcare

GP

Goodwin Procter LLP

The Business Of Breakthroughs: Mayo Clinic On Innovation And The Future Of Care (Video)

United States Healthcare

AM

Alvarez & Marsal

A New "Made In America" Push For Hospitals: CMS Seeks Input On Domestic Sourcing For PPE And Essential Medicines

United States Healthcare

PL

Polsinelli LLP

Reforms To FDA Requirements For Cell And Gene Therapy Products

United States Healthcare

GP

Goodwin Procter LLP

The Empty Chair At Johannesburg: What It Says About US Power

United States International

SJ

Steptoe LLP

The Mediation Timing Dilemma: Four Factors Every General Counsel Should Consider

United States Litigation

J

JAMS

Federal Government Continues Anti-Fraud Enforcement In The Sports Industry And Signals Desire To Work Cooperatively With Organizations Under Investigation

United States Criminal

SJ

Steptoe LLP

Colorado "Opt-Out" Litigation – Petition For Rehearing En Banc And Amicus Briefs In Support

United States Finance

BS

Ballard Spahr LLP

Signed, Sealed, But Not Delivered? Don't Wonder About Taxes Under New Postal Service Rules

United States Tax

N

Nossaman LLP

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Life Sciences, Biotechnology & Nanotechnology

NSF Will Establish National Quantum And Nanotechnology Research Infrastructure; Letters Of Intent Are Due March 16, 2026

The U.S. National Science Foundation (NSF) announced on February 13, 2026, that it is investing up to $100 million to establish a nationwide network of open-access research facilities for quantum and nanoscale technologies...

United States Healthcare

BC

Bergeson & Campbell

Life Sciences Dealmaking Accelerates In 2026: Key Insights From EY's Firepower M&A Report

According to Ernst and Young's (EY) 2026 Firepower M&A Report, dealmaking is accelerating — driven not by short-term market shifts, but by long-term strategic fundamentals.

United States Healthcare

SR

McDermott Will & Schulte

Genetic Testing Enforcement Poised To Rise: What To Expect In The Coming Year

On January 28, 2026, the U.S. Department of Health and Human Services Office of Inspector General ("HHS OIG") released a report, "Total Medicare Part B Spending on Lab Tests Rose in 2024, Driven by Increased Spending...

United States Healthcare

KM

Katten Muchin Rosenman LLP

Samsung And Regeneron Settle Aflibercept BPCIA Case

United States Healthcare

GP

Goodwin Procter LLP

Reforms To FDA Requirements For Cell And Gene Therapy Products

United States Healthcare

GP

Goodwin Procter LLP

Oliver Twisted Again: After FDA's Court Losses, Congress Approves FDA's Standards On Orphan Drug Exclusivity

United States Healthcare

AV

Axinn Veltrop & Harkrider

2026 Top-of-Mind Issues For Life Sciences Companies

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

J.P. Morgan Healthcare Conference 2026: Recap And What To Watch

United States Healthcare

BS

Ballard Spahr LLP

2026 Global Corporate Practice Transaction Highlights

United States Commercial

KG

K&L Gates LLP

See more

Healthcare

Consolidated Appropriations Act Introduces Sweeping Reforms For Pharmacy Benefit Managers

PBMs contracted with group health plans will similarly need to remit to plans any rebates, fees, alternative discounts, and other remuneration received relating to utilization of drugs or drug spending.

United States Healthcare

CM

Crowell & Moring LLP

OIG Issues Medicare Advantage Industry Segment-Specific Compliance Program Guidance, Creating Implications For Downstream Entities

The U.S. Department of Health and Human Services' Office of Inspector General (OIG) has released updated Medicare Advantage Industry Segment-Specific Compliance Program...

United States Healthcare

DM

Duane Morris LLP

The Wait Is Over: Information Blocking Enforcement Is Officially Here

The U.S. Department of Health and Human Services is moving from policy to enforcement under the 21st Century Cures Act...

United States Healthcare

HK

Holland & Knight

Cost Efficiency And Ethical Healthcare Will Increasingly Become Non-negotiable

United States Healthcare

AM

Alvarez & Marsal

Testing The Boundaries Of Artificial Intelligence In Care Delivery: Utah's Prescription Renewal Pilot Program

United States Technology

SM

Sheppard, Mullin, Richter & Hampton LLP

Reminder: Comments To The HHS Request For Information On Accelerating AI Adoption In Clinical Care Due February 23, 2026.

United States Technology

KM

Katten Muchin Rosenman LLP

Genetic Testing Enforcement Poised To Rise: What To Expect In The Coming Year

United States Healthcare

KM

Katten Muchin Rosenman LLP

Sweeping PBM Reforms Arrive: What The 2026 Federal Legislation Means For Pharmacies, Patients And Employers

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Express Scripts Settles PBM FTC Action And Must Make Fundamental Changes To PBM Model

United States Healthcare

GP

Goodwin Procter LLP

See more

Food and Drugs Law

Consolidated Appropriations Act Introduces Sweeping Reforms For Pharmacy Benefit Managers

PBMs contracted with group health plans will similarly need to remit to plans any rebates, fees, alternative discounts, and other remuneration received relating to utilization of drugs or drug spending.

United States Healthcare

CM

Crowell & Moring LLP

Genetic Testing Enforcement Poised To Rise: What To Expect In The Coming Year

On January 28, 2026, the U.S. Department of Health and Human Services Office of Inspector General ("HHS OIG") released a report, "Total Medicare Part B Spending on Lab Tests Rose in 2024, Driven by Increased Spending...

United States Healthcare

KM

Katten Muchin Rosenman LLP

Sweeping PBM Reforms Arrive: What The 2026 Federal Legislation Means For Pharmacies, Patients And Employers

ONn February 3, 2026, Congress enacted the Consolidated Appropriations Act, 2026, marking a watershed moment in the regulation of pharmacy benefit managers (PBMs).

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Express Scripts Settles PBM FTC Action And Must Make Fundamental Changes To PBM Model

United States Healthcare

GP

Goodwin Procter LLP

A New "Made In America" Push For Hospitals: CMS Seeks Input On Domestic Sourcing For PPE And Essential Medicines

United States Healthcare

PL

Polsinelli LLP

Federal Courts Push Back: Three Decisions Chart A Path For Challenging Administrative Subpoenas

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

What To Watch: OPDP Off To A Roaring 2026

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

FTC Lands Landmark Settlement With Express Scripts Over Insulin Rebate Practices

United States Healthcare

CO

Cozen O'Connor

Republican Senator Accuses CVS CEO Of Fraud, Regulatory Violations, And Inflated Health Care Costs

United States Employment

HB

Hall Benefits Law

See more

Latest Videos

See more

Digging Into New York's New Price-Gouging Rules (Video)

BS

Bond, Schoeneck & King PLLC

Repair, Refocus, Reimagine: Michele Volpe Leads Penn Medicine To Sustainable Growth (Video)

AM

Alvarez & Marsal

Pay Transparency + The Power Of Preventive Strategies: Episode 3 — Pivoting Toward Preparation In The Life Sciences (Video)

JL

Jackson Lewis P.C.

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

FL

Foley & Lardner

Critical Medical Device Series: Part X Balancing Risk And Innovation: Fraud And Abuse Trends For MedTech (Video)

AP

Arnold & Porter

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More